Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Promising clinical results reported for Avakine

Nov. 13, 1997

New class of TNF-alpha inhibitors safe and well tolerated in phase I

Nov. 12, 1997

rhIL-1ra provides long-term improvement in RA

Nov. 11, 1997

Clinical results reported for leflunomide in refractory RA and Wegener's granulomatosis

Nov. 11, 1997

Humanized anti-CD4 MAb suppresses synovial inflammation/cytokine levels

Nov. 11, 1997

MK-966 assessed in large trial in osteoarthritis of the knee and hip

Nov. 11, 1997

TNF/PDE inhibitors disclosed by Rhone-Poulenc Rorer

Nov. 6, 1997

MMP inhibitors reported by ProScript

Nov. 5, 1997

Peptides for autoimmune/inflammatory diseases linked to MHC molecules

Nov. 5, 1997

Mechanism of glucocorticoid antiinflammatory effects elucidated

Oct. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...